EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Engineered Delivery Systems for Chinese Herbal Medicine in Peripheral Nerve Regeneration: Challenges, Advances, and Future Perspectives

Ruirui Zhang iD, Miao Gu, Rui Ma, Rong Li, Shijie Xu, Zhipeng Xu

Drug Design, Development and Therapy · 2025

DOI: 10.2147/dddt.s563805 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Ruirui Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Province Key Laboratory of Medical Science and Laboratory Medicine, Department of Laboratory Medicine, School of Medicine, Jiangsu University…. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Nerve Regeneration, Drug Delivery Systems, Peripheral Nervous System Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peripheral neuropathy (PN), characterized by sensory, motor, and autonomic dysfunction, presents a significant therapeutic challenge owing to its diverse etiologies, dynamic spatiotemporal injury microenvironment, and impermeable blood-nerve barrier (BNB). The current treatment is mainly palliative and symptom-focused, and fails to solve the core pathological complexity, including the heterogeneity of nerve injury, the conflicting phases of inflammation, repair, and fibrosis, and the imbalance of the microenvironment in chronic conditions such as diabetes. Chinese herbal medicine (CHM) has multiple benefits including neuroprotective, anti-inflammatory, anti-oxidant, and microenvironmental regulation. However, its clinical translation is hindered by poor bioavailability, non-targeted biodistribution, BNB exclusion, and physicochemical mismatches in multicomponent formulations. Preclinical studies suggest that engineered delivery systems could emerge as a transformative solution to these limitations. Nanocarriers penetrate the BNB via diffusion or ligand-mediated targeting, offering spatiotemporal control through a stimulus-responsive design. Hydrogels align their degradation processes with nerve regeneration and correct the imbalanced microenvironments. Degradable membranes offer localized, sustained release, whereas functionalized nerve conduits address structural defects and improve functional recovery beyond autograft limitations. Despite promising preclinical efficacy, clinical translation faces significant hurdles, including long-term biocompatibility concerns, inconsistent scalability in manufacturing, dosage optimization balancing efficacy and cytotoxicity, dependence on external stimuli, and a lack of standardized regulatory frameworks. Overcoming these challenges requires interdisciplinary collaboration to advance intelligent multifunctional designs, scalable production, and rigorous validations. Based on compelling preclinical data, engineered CHM delivery systems are hypothesized to have enormous potential to transform PN management from palliative care to restorative treatment and establish a new framework in precision neurology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalNerve RegenerationDrug Delivery SystemsPeripheral Nervous System DiseasesPeripheral NervesHumansAnimals

Stichwörter der Autor:innen

CHMChinese herbal medicineengineered delivery systemsperipheral neuropathy

Substanzen

Drugs, Chinese Herbal

Autor:innen und Institutionen

  • Jiangsu Province Key Laboratory of Medical Science and Laboratory Medicine, Department of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, 212013, People's Republic of China.
  • Department of Anatomy, School of Medicine, Jiangsu University, Zhenjiang, 212013, People's Republic of China.
  • Hebei Key Laboratory of Nerve Injury and Repair, Chengde Medical University, Chengde, Hebei, People's Republic of China.
  • Department of Urology, Affiliated People's Hospital of Jiangsu University, The First People's Hospital of Zhenjiang, Zhenjiang, Jiangsu, 212002, People's Republic of China.

ORCID-Profile: Ruirui Zhang

Zitieren

APA

Zhang, R., Gu, M., Ma, R., Li, R., Xu, S., & Xu, Z. (2025). Engineered Delivery Systems for Chinese Herbal Medicine in Peripheral Nerve Regeneration: Challenges, Advances, and Future Perspectives. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s563805

Vancouver

Zhang R, Gu M, Ma R, Li R, Xu S, Xu Z. Engineered Delivery Systems for Chinese Herbal Medicine in Peripheral Nerve Regeneration: Challenges, Advances, and Future Perspectives. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s563805

BibTeX
@article{Zhang2025,
  author = {Zhang, Ruirui and Gu, Miao and Ma, Rui and Li, Rong and Xu, Shijie and Xu, Zhipeng},
  title = {Engineered Delivery Systems for Chinese Herbal Medicine in Peripheral Nerve Regeneration: Challenges, Advances, and Future Perspectives},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  doi = {10.2147/dddt.s563805}
}
Kostenlos starten →